A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

S. A. Ghamande; M. Silverman; M. Gold

doi:10.1016/j.ygyno.2009.03.012

A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

S. A. Ghamande, M. Silverman, M. Gold

Obstetrics and Gynecology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	137
Number of pages	1
Journal	Gynecologic Oncology
Volume	114
Issue number	1
DOIs	https://doi.org/10.1016/j.ygyno.2009.03.012
State	Published - Jul 2009

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ygyno.2009.03.012

Cite this

A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer. / Ghamande, S. A.; Silverman, M.; Gold, M.
In: Gynecologic Oncology, Vol. 114, No. 1, 07.2009, p. 137.

Research output: Contribution to journal › Letter › peer-review

@article{245db4ba3d2b4fd898b9af7f89517e3d,

title = "A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer",

author = "Ghamande, {S. A.} and M. Silverman and M. Gold",

year = "2009",

month = jul,

doi = "10.1016/j.ygyno.2009.03.012",

language = "English (US)",

volume = "114",

pages = "137",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

AU - Ghamande, S. A.

AU - Silverman, M.

AU - Gold, M.

PY - 2009/7

Y1 - 2009/7

UR - http://www.scopus.com/inward/record.url?scp=67349174252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349174252&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2009.03.012

DO - 10.1016/j.ygyno.2009.03.012

M3 - Letter

AN - SCOPUS:67349174252

SN - 0090-8258

VL - 114

SP - 137

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 1

ER -

A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this